Built on Over a Decade of Research
at the Cambridge Memory Lab



Where Neuroscience Meets
Clinical Expertise
PREMAZ is built on the concept of "precision memory", a well researched paradigm borne out of Cambridge University.
In 2023, medical doctor Julia Cooney and Cambridge neuroscientist Professor Jon Simons joined forces with a shared vision: to bring this powerful research tool into the hands of clinicians. Combining Julia’s medical insight with Jon’s pioneering neuroscience, they transformed a decade of lab-based innovation into a clinically ready platform, bridging the gap between cutting-edge cognitive science and real-world clinical care.
Proven in Research. Trusted in Clinical Practice.
6+
Published Clinical Studies
Independent peer-reviewed publications confirming test sensitivity, reproducibility, and cross-population consistency.
1000+
Tested patients
Data collected from healthy controls, MCI, and clinical groups across North America and Europe.
10+
Years of Research
Beginning as the precision memory paradigm developed by Cambridge University, and later morphing into the PREMAZ test.
Over the past decade, the PREMAZ methodology has been extensively tested in academic research settings, forming a strong foundation of peer-reviewed evidence. Building on this groundwork, PREMAZ is now being introduced into clinical environments to evaluate its real-world performance and utility as a screening tool. While further research is ongoing, early findings suggest that PREMAZ can provide meaningful insights into cognitive health and support earlier detection of impairment.
Discover our Latest Publications
Interested in using PREMAZ for research or clinical use?
Reach out to our partnerships team to discuss validation data, regulatory alignment, or integration into ongoing studies.















